Skip to main content
Livermore
Livermore
ZHEN

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

BIO holding history

Bio-Rad Laboratories, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BIO overviewAll 13F holders of BIOFull Q2 2026 holdings

Shares (Q2 2026)
2,176
Value
$638.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BIO by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,176$638.9K<0.1%−49−2.2%ReducedHolders
Q1 20262,225$620.2K<0.1%+527+31.0%AddedHolders
Q4 20251,698$514.5K<0.1%−367−17.8%ReducedHolders
Q3 20252,065$579.0K<0.1%−68−3.2%ReducedHolders
Q2 20252,133$514.7K<0.1%−1,075−33.5%ReducedHolders
Q1 20253,208$781.3K<0.1%−17−0.5%ReducedHolders
Q4 20243,225$1.06M<0.1%+97+3.1%AddedHolders
Q3 20243,128$1.05M<0.1%+330+11.8%AddedHolders
Q2 20242,798$764.2K<0.1%−263−8.6%ReducedHolders
Q1 20243,061$1.06M<0.1%+327+12.0%AddedHolders
Q4 20232,734$882.8K<0.1%−562−17.1%ReducedHolders
Q3 20233,296$1.18M<0.1%+135+4.3%AddedHolders
Q2 20233,161$1.20M<0.1%+211+7.2%AddedHolders
Q1 20232,950$1.41M<0.1%−9−0.3%ReducedHolders
Q4 20222,959$1.24M<0.1%+562+23.4%AddedHolders
Q3 20222,397$1.00M<0.1%+312+15.0%AddedHolders
Q2 20222,085$1.03M<0.1%−4,387−67.8%ReducedHolders
Q1 20226,472$3.65M0.1%−6,376−49.6%ReducedHolders
Q4 202112,848$9.71M0.2%+260+2.1%AddedHolders
Q3 202112,588$9.39M0.2%+7,102+129.5%AddedHolders
Q2 20215,486$3.54M0.1%−1,228−18.3%ReducedHolders
Q1 20216,714$3.83M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.